Emerging evidence has implicated chronically elevated SAA in the pathogenesis of several cardiometabolic diseases, including obesity, type 2 diabetes mellitus (T2DM), MASLD and hypertension [18, 69, 105, 125, 168]. The gene discussed is SAA1; the disease is obesity due to melanocortin 4 receptor deficiency.